Current News

Contact | Print version | Send article | RSS feed

Dyax Corp. and CSIRO Form Joint Antibody Discovery Collaboration in Oncology

01 Dec 2006 - Dyax Corp. and the Division of Molecular and Health Technologies of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national scientific research agency, announced that they have entered into a collaboration for the discovery and development of therapeutic antibodies to treat cancer.
 
During the discovery phase of the collaboration, Dyax will utilize its proprietary antibody libraries to screen for clinical candidates, and CSIRO will provide reagents and in vitro assays, as well as certain in vivo and preclinical development work. Upon successful completion of the discovery work, CSIRO and Dyax will have the option to advance the antibody lead(s) into clinical development under the terms of a global co-development and commercialization agreement.